Catalyst Wire Dossier Catalyst Wire Dossier

STIMUFEND

PEGFLILGRASTIM-FPGK · Fresenius Kabi USA, LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for STIMUFEND, covering 2022-04-04 to 2025-10-21. Get the full timeline:

Most recent: FDA Approved: STIMUFEND — Supplemental Application (Fresenius Kabi USA, LLC)

See pricing